
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Risperidone administered during adolescence induced metabolic, anatomical and inflammatory/oxidative changes in adult brain: A PET and MRI study in the maternal immune stimulation animal model
Marta Casquero‐Veiga, David García‐García, Karina S. MacDowell, et al.
European Neuropsychopharmacology (2019) Vol. 29, Iss. 7, pp. 880-896
Closed Access | Times Cited: 28
Marta Casquero‐Veiga, David García‐García, Karina S. MacDowell, et al.
European Neuropsychopharmacology (2019) Vol. 29, Iss. 7, pp. 880-896
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Present and future antipsychotic drugs: A systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective
Andrea de Bartolomeis, Annarita Barone, Veronica Begni, et al.
Pharmacological Research (2022) Vol. 176, pp. 106078-106078
Open Access | Times Cited: 39
Andrea de Bartolomeis, Annarita Barone, Veronica Begni, et al.
Pharmacological Research (2022) Vol. 176, pp. 106078-106078
Open Access | Times Cited: 39
Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
Giuseppe Caruso, Margherita Grasso, Annamaria Fidilio, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 457-457
Open Access | Times Cited: 69
Giuseppe Caruso, Margherita Grasso, Annamaria Fidilio, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 457-457
Open Access | Times Cited: 69
Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis
Yang Mi, Chunzhi Wang, Guocheng Zhao, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 2, pp. 340-352
Open Access | Times Cited: 16
Yang Mi, Chunzhi Wang, Guocheng Zhao, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 2, pp. 340-352
Open Access | Times Cited: 16
N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia
Diego Romero‐Miguel, Marta Casquero‐Veiga, Nicolás Lamanna‐Rama, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Diego Romero‐Miguel, Marta Casquero‐Veiga, Nicolás Lamanna‐Rama, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Identification of immune-related biomarkers in peripheral blood of schizophrenia using bioinformatic methods and machine learning algorithms
Xiaoli Zhu, C. Wang, Jianfeng Yu, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 8
Xiaoli Zhu, C. Wang, Jianfeng Yu, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 8
Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study
Xirong Li, Mei Hong Xiu, Xiao Guan, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 1316-1324
Open Access | Times Cited: 20
Xirong Li, Mei Hong Xiu, Xiao Guan, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 1316-1324
Open Access | Times Cited: 20
Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia
Vicent Llorca-Bofí, Santiago Madero, Sílvia Amoretti, et al.
Schizophrenia Research (2024) Vol. 267, pp. 24-31
Closed Access | Times Cited: 2
Vicent Llorca-Bofí, Santiago Madero, Sílvia Amoretti, et al.
Schizophrenia Research (2024) Vol. 267, pp. 24-31
Closed Access | Times Cited: 2
Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C
Marta Casquero‐Veiga, Diego Romero‐Miguel, Karina S. MacDowell, et al.
European Neuropsychopharmacology (2021) Vol. 46, pp. 14-27
Closed Access | Times Cited: 17
Marta Casquero‐Veiga, Diego Romero‐Miguel, Karina S. MacDowell, et al.
European Neuropsychopharmacology (2021) Vol. 46, pp. 14-27
Closed Access | Times Cited: 17
A Characterization of the Effects of Minocycline Treatment During Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders
Diego Romero‐Miguel, Marta Casquero‐Veiga, Karina S. MacDowell, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 24, Iss. 9, pp. 734-748
Open Access | Times Cited: 16
Diego Romero‐Miguel, Marta Casquero‐Veiga, Karina S. MacDowell, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 24, Iss. 9, pp. 734-748
Open Access | Times Cited: 16
The effects of mango leaf extract during adolescence and adulthood in a rat model of schizophrenia
José Antonio Garcia-Partida, Sonia Torres-Sánchez, Karina S. MacDowell, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
José Antonio Garcia-Partida, Sonia Torres-Sánchez, Karina S. MacDowell, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study
Haixia Liu, Rui Yu, Yanan Gao, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1774-1782
Open Access | Times Cited: 14
Haixia Liu, Rui Yu, Yanan Gao, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1774-1782
Open Access | Times Cited: 14
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study
Haixia Liu, Hua Liu, Shuling Jiang, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1793-1803
Open Access | Times Cited: 13
Haixia Liu, Hua Liu, Shuling Jiang, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1793-1803
Open Access | Times Cited: 13
The Poly I:C maternal immune stimulation model shows unique patterns of brain metabolism, morphometry, and plasticity in female rats
Marta Casquero‐Veiga, Nicolás Lamanna‐Rama, Diego Romero‐Miguel, et al.
Frontiers in Behavioral Neuroscience (2023) Vol. 16
Open Access | Times Cited: 5
Marta Casquero‐Veiga, Nicolás Lamanna‐Rama, Diego Romero‐Miguel, et al.
Frontiers in Behavioral Neuroscience (2023) Vol. 16
Open Access | Times Cited: 5
Establishment of an assistive diagnostic model for schizophrenia with oxidative stress biomarkers
Shuying Wang, Xiuxia Yuan, Lijuan Pang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Shuying Wang, Xiuxia Yuan, Lijuan Pang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Maternal Supplementation with N-Acetylcysteine Modulates the Microbiota-Gut-Brain Axis in Offspring of the Poly I:C Rat Model of Schizophrenia
Diego Romero‐Miguel, Marta Casquero‐Veiga, Javier Fernández, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 970-970
Open Access | Times Cited: 5
Diego Romero‐Miguel, Marta Casquero‐Veiga, Javier Fernández, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 970-970
Open Access | Times Cited: 5
Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways
Karina S. MacDowell, Eva Munarriz‐Cuezva, J. Javier Meana, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 11
Karina S. MacDowell, Eva Munarriz‐Cuezva, J. Javier Meana, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 11
Supplement Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy Partially Prevents Schizophrenia-Related Outcomes in the Poly I:C Rat Model
Henriette Edemann-Callesen, Nadine Bernhardt, Elizabeth Barroeta Hlusicka, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1068-1068
Open Access | Times Cited: 4
Henriette Edemann-Callesen, Nadine Bernhardt, Elizabeth Barroeta Hlusicka, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1068-1068
Open Access | Times Cited: 4
Immune Activation in Pregnant Rats Affects Brain Glucose Consumption, Anxiety-like Behaviour and Recognition Memory in their Male Offspring
Cyprien G.J. Guerrin, Alexandre Shoji, Janine Doorduin, et al.
Molecular Imaging and Biology (2022) Vol. 24, Iss. 5, pp. 740-749
Open Access | Times Cited: 6
Cyprien G.J. Guerrin, Alexandre Shoji, Janine Doorduin, et al.
Molecular Imaging and Biology (2022) Vol. 24, Iss. 5, pp. 740-749
Open Access | Times Cited: 6
(R)-ketamine attenuates neurodevelopmental disease-related phenotypes in a mouse model of maternal immune activation
Elifrances Galdino de Oliveira, Diógenes Afonso de Lima, José Carlos da Silva Júnior, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1501-1512
Closed Access | Times Cited: 3
Elifrances Galdino de Oliveira, Diógenes Afonso de Lima, José Carlos da Silva Júnior, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1501-1512
Closed Access | Times Cited: 3
THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation
Nicolás Lamanna‐Rama, Diego Romero‐Miguel, Marta Casquero‐Veiga, et al.
Psychiatry Research (2023) Vol. 331, pp. 115643-115643
Closed Access | Times Cited: 3
Nicolás Lamanna‐Rama, Diego Romero‐Miguel, Marta Casquero‐Veiga, et al.
Psychiatry Research (2023) Vol. 331, pp. 115643-115643
Closed Access | Times Cited: 3
Caffeine-Induced Acute and Delayed Responses in Cerebral Metabolism of Control and Schizophrenia-like Wisket Rats
Gyöngyi Horváth, István Kertész, Tamás Nagy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8186-8186
Open Access | Times Cited: 5
Gyöngyi Horváth, István Kertész, Tamás Nagy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8186-8186
Open Access | Times Cited: 5
Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier
Biomedicines (2021) Vol. 9, Iss. 5, pp. 473-473
Open Access | Times Cited: 6
Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier
Biomedicines (2021) Vol. 9, Iss. 5, pp. 473-473
Open Access | Times Cited: 6
The long-term effects of adolescent Δ9-tetrahydrocannabinol on brain structure and function assessed through neuroimaging techniques in male and female rats
Javier Orihuel, Roberto Capellán, Marta Casquero‐Veiga, et al.
European Neuropsychopharmacology (2023) Vol. 74, pp. 47-63
Open Access | Times Cited: 2
Javier Orihuel, Roberto Capellán, Marta Casquero‐Veiga, et al.
European Neuropsychopharmacology (2023) Vol. 74, pp. 47-63
Open Access | Times Cited: 2
A Novel Bayesian Linear Regression Model for the Analysis of Neuroimaging Data
Albert Belenguer-Llorens, Carlos Sevilla-Salcedo, Manuel Desco, et al.
Applied Sciences (2022) Vol. 12, Iss. 5, pp. 2571-2571
Open Access | Times Cited: 2
Albert Belenguer-Llorens, Carlos Sevilla-Salcedo, Manuel Desco, et al.
Applied Sciences (2022) Vol. 12, Iss. 5, pp. 2571-2571
Open Access | Times Cited: 2
Positron Emission Tomography of the Reward System
Diego Romero‐Miguel, Nicolás Lamanna‐Rama, Marta Casquero‐Veiga, et al.
Neuromethods (2020), pp. 281-305
Closed Access | Times Cited: 1
Diego Romero‐Miguel, Nicolás Lamanna‐Rama, Marta Casquero‐Veiga, et al.
Neuromethods (2020), pp. 281-305
Closed Access | Times Cited: 1